These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38627727)

  • 1. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.
    Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z
    BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma.
    Zhu L; Lou Y; Xiao Q; Wang L; Chen G; Yang W; Wang T
    Biochem Genet; 2024 Apr; 62(2):698-717. PubMed ID: 37405532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.
    Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z
    BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
    Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
    Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S; Bai H; Fei S; Miao B
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
    Li R; Zhao W; Liang R; Jin C; Xiong H
    Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
    [No Abstract]   [Full Text] [Related]  

  • 10. Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma.
    Li H; Li J; Qu X; Dai H; Liu J; Ma M; Wang J; Dong W; Wang W
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17543-17557. PubMed ID: 37903936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma.
    Zuo B; Kuai J; Long J; Bian J; Yang X; Yang X; Xun Z; Li Y; Sun H; Sang X; Zhao H
    Ann Transl Med; 2022 Aug; 10(15):817. PubMed ID: 36034976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma.
    Dong W; Xie Y; Huang H
    Front Endocrinol (Lausanne); 2022; 13():884777. PubMed ID: 35733776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach.
    Hai L; Bai XY; Luo X; Liu SW; Ma ZM; Ma LN; Ding XC
    Front Immunol; 2024; 15():1444091. PubMed ID: 39445019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
    Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
    Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma.
    Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L
    Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and potential mechanism of cellular senescence and tumor microenvironment in hepatocellular carcinoma: Insights from bulk transcriptomics and single-cell sequencing analysis.
    Qu C; Wu Q; Lu J; Li F
    Environ Toxicol; 2024 May; 39(5):2512-2527. PubMed ID: 38189188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making.
    Chen J; Gao G; He Y; Zhang Y; Wu H; Dai P; Zheng Q; Huang H; Weng J; Zheng Y; Huang Y
    Sci Rep; 2023 Dec; 13(1):22624. PubMed ID: 38114725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network.
    Zhang HY; Zhu JJ; Liu ZM; Zhang YX; Chen JJ; Chen KD
    Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):272-287. PubMed ID: 37407412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.